Exousia Bio, Inc. (LMMY)
↓ Download CSV- Sector Services
- Incorporated WY
- Fiscal year ends May 31
In fiscal 2025, Exousia Bio, Inc. reported revenue of $3.8K, down 67.4% from the prior year. The company was profitable, with a net margin of 1370.5% and a gross margin of -93.4%. It held $0 in total assets against $0 in total liabilities.
Key ratios (FY2025)
-93.4%
Gross margin
1370.5%
Net margin
-67.4%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $3.8K | $11.5K | $0 | — |
| Cost of Revenue | $7.3K | $9.7K | $0 | — |
| Gross Profit | -$3.5K | $1.8K | $0 | — |
| Operating Income | — | — | -$56.4K | — |
| Net Income | $51.4K | -$25.8K | -$56.4K | — |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | — |
| Total Assets | $0 | $27.5K | $37.0K | $54.0K |
| Total Liabilities | $0 | $82.3K | $66.1K | $54.4K |
| Shareholders' Equity | $0 | -$54.9K | -$29.1K | -$437 |
| Cash & Equivalents | — | — | $7.9K | $10.1K |
| Operating Cash Flow | -$4.5K | -$12.5K | -$38.1K | — |
| Shares Outstanding | 7.78M | 7.78M | 7.78M | 5.00M |